Main menu

Thomas C. Wolski
Director and Vice President
Webb Law | Thomas C. Wolski
Webb Law | Thomas C. Wolski


Thomas C. Wolski concentrates his practice on many aspects of intellectual property, including: patent prosecution, licensing and client counseling on intellectual property, and intellectual property litigation. He has obtained patents for clients in areas of small and large molecule therapeutics, cancer diagnostic and treatments, hormone replacement therapies, engineered tissue, engineered and cultivated organisms (e.g. plants, microbes and viruses), and medical devices. Tom has handled cases involving medical devices, dietary supplements, emulsions, and valves, as well as trademarks, copyrights, trade secrets, licenses, and employment contracts. In addition, he has negotiated many licenses and intellectual property transfers.

Tom joined The Webb Law Firm in 2007 as an associate and became a partner in 2012. Before joining the firm, he practiced in New York City where he handled complex litigation across the country, encompassing a wide-range of commercial matters. He also was a laboratory manager and research specialist at the University of Pittsburgh in molecular biology and biochemistry, focusing his studies on premature birth and cardiovascular diseases. 


Registered Patent Attorney, U.S. Patent and Trademark Office

Bar Admissions

New York, 2003
U.S. District Court for the Southern District of New York, 2004
U.S. District Court for the Eastern District of New York, 2004
Pennsylvania, 2006


Syracuse University College of Law, Syracuse, New York, 2002 J.D.
Certificate of Law, Technology and Management, 2002

University of Pittsburgh, Pittsburgh, Pennsylvania, 1998 B.S.
Major: Biology

Professional Associations and Memberships

Association of the Bar of the City of New York: Young Lawyers’ Committee and National Moot Court Problem Drafting Committee
Pennsylvania BIO



Main Practice Areas: 
Experience Includes: 


Recent Publications: 

London, B., T., Wolski, et al. “Slow conduction of premature beats leads to ventricular tachycardia in a TNF-α transgenic model of congestive heart failure,” CIRCULATION, 100:I-207, 1999

London B, Wolski TC, et al., “AFR Cloning and characterization of a highly polymorphic mixed dinucleotide repeat in the HERG promoter,” CIRCULATION 100 (18): 316 Suppl. S NOV 2 1999